Projects per year
Personal profile
Research Strategic Pillar
Dr. Randall Urban, VP and Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Specialized Health
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
-
Grant #85400: Inhibition of bacterial and host H2S for antimicrobial defense after burns
1/1/17 → 8/31/19
Project: Other project
-
Grant #85400: Inhibition of bacterial and host H2S for antimicrobial defense after burns
Shriners Hospitals for Children - Texas
1/1/17 → 8/31/19
Project: Other project
-
Inhibition of Bacterial and Host-Derived H2S Production for the Therapeutic Enhancement of Anti-Bacterial Host Defense
12/1/16 → 11/30/19
Project: Other project
-
Current problems in burn immunology
Blears, E., Sommerhalder, C., Toliver-Kinsky, T., Finnerty, C. C. & Herndon, D. N., Jun 2020, In: Current Problems in Surgery. 57, 6, 100779.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Hydrogen sulfide: An endogenous regulator of the immune system
Dilek, N., Papapetropoulos, A., Toliver-Kinsky, T. & Szabo, C., Nov 2020, In: Pharmacological Research. 161, 105119.Research output: Contribution to journal › Review article › peer-review
Open Access123 Scopus citations -
In brief
Blears, E., Sommerhalder, C., Toliver-Kinsky, T., Finnerty, C. C. & Herndon, D. N., Jun 2020, In: Current Problems in Surgery. 57, 6, 100781.Research output: Contribution to journal › Comment/debate › peer-review
-
H 2 S, a bacterial defense mechanism against the host immune response
Toliver-Kinsky, T., Cui, W., Törö, G., Lee, S. J., Shatalin, K., Nudler, E. & Szaboa, C., Jan 1 2019, In: Infection and immunity. 87, 1, e00272.Research output: Contribution to journal › Article › peer-review
Open Access59 Scopus citations -
The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis
Ahmad, A., Vieira, J. D. C., de Mello, A. H., de Lima, T. M., Ariga, S. K., Barbeiro, D. F., Barbeiro, H. V., Szczesny, B., Törö, G., Druzhyna, N., Randi, E. B., Marcatti, M., Toliver-Kinsky, T., Kiss, A., Liaudet, L., Salomao, R., Soriano, F. G. & Szabo, C., Jul 2019, In: Pharmacological Research. 145, 104263.Research output: Contribution to journal › Article › peer-review
Open Access22 Scopus citations